<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T18:13:28Z</responseDate>
  <request identifier="oai:figshare.com:article/33975142" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33975142</identifier>
        <datestamp>2026-09-23T17:25:50Z</datestamp>
        <setSpec>category_146</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Drug resistance among bacteriologically confirmed TB patients by patient risk category.&lt;/p&gt;</dc:title>
          <dc:creator>Phallon Blessing Mwaba (25073412)</dc:creator>
          <dc:creator>Marshal Sikandangwa (25098997)</dc:creator>
          <dc:creator>Robertson Chibumbya (25099000)</dc:creator>
          <dc:creator>Innocent Mwaba (18158388)</dc:creator>
          <dc:creator>Minyoi Mubita Maimbolwa (18137037)</dc:creator>
          <dc:creator>Chitalu Chanda (21354901)</dc:creator>
          <dc:creator>Muhammad Mputu (24559881)</dc:creator>
          <dc:creator>Rhehab Chimzizi (41700)</dc:creator>
          <dc:creator>Kevin Mabvuto Zimba (25099003)</dc:creator>
          <dc:creator>Nancy Kasese Chanda (25073421)</dc:creator>
          <dc:creator>Angel Mubanga (19670074)</dc:creator>
          <dc:creator>Monde Muyoyeta (372849)</dc:creator>
          <dc:creator>Mary Kagujje (9362116)</dc:creator>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>routine diagnostic algorithms</dc:subject>
          <dc:subject>rif ultra among</dc:subject>
          <dc:subject>major diagnostic gap</dc:subject>
          <dc:subject>guide individualized treatment</dc:subject>
          <dc:subject>analyzed patient demographics</dc:subject>
          <dc:subject>tb cases ).</dc:subject>
          <dc:subject>week active drug</dc:subject>
          <dc:subject>improve early drug</dc:subject>
          <dc:subject>resistant tb cases</dc:subject>
          <dc:subject>tb burden facilities</dc:subject>
          <dc:subject>xdr platform regardless</dc:subject>
          <dc:subject>xdr assay offers</dc:subject>
          <dc:subject>resistance categories descriptively</dc:subject>
          <dc:subject>reflex xpert mtb</dc:subject>
          <dc:subject>rising drug resistance</dc:subject>
          <dc:subject>resistant tuberculosis detection</dc:subject>
          <dc:subject>zambia &lt;/ p</dc:subject>
          <dc:subject>xdr tb results</dc:subject>
          <dc:subject>rifampicin resistant drug</dc:subject>
          <dc:subject>drug resistance drug</dc:subject>
          <dc:subject>including isoniazid mono</dc:subject>
          <dc:subject>xdr tb</dc:subject>
          <dc:subject>resistant tuberculosis</dc:subject>
          <dc:subject>xpert mtb</dc:subject>
          <dc:subject>tuberculosis burden</dc:subject>
          <dc:subject>multisite drug</dc:subject>
          <dc:subject>rapid detection</dc:subject>
          <dc:subject>resistance drug</dc:subject>
          <dc:subject>xdr testing</dc:subject>
          <dc:subject>xdr results</dc:subject>
          <dc:subject>yet diagnosis</dc:subject>
          <dc:subject>successfully retrieved</dc:subject>
          <dc:subject>programmatic data</dc:subject>
          <dc:subject>prevent amplification</dc:subject>
          <dc:subject>may 2025</dc:subject>
          <dc:subject>five provinces</dc:subject>
          <dc:subject>centric diagnostics</dc:subject>
          <dc:subject>bacteriologically confirmed</dc:subject>
          <dc:description>&lt;p&gt;Drug resistance among bacteriologically confirmed TB patients by patient risk category.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-23T17:25:43Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pgph.0005536.t003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Drug_resistance_among_bacteriologically_confirmed_TB_patients_by_patient_risk_category_p_/33975142</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
